These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20066732)

  • 81. How Common-and How Serious- Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset.
    Bovonratwet P; Bohl DD; Russo GS; Ondeck NT; Nam D; Della Valle CJ; Grauer JN
    Clin Orthop Relat Res; 2018 Mar; 476(3):453-462. PubMed ID: 29443839
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.
    Biswal S
    Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Clostridium difficile diarrhea in the very old. Clinical features and course in 21 cases].
    Fraisse A; Croix C; Manière D; Pfitzenmeyer P
    Presse Med; 1999 Oct; 28(32):1748-52. PubMed ID: 10566275
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Emergence of Clostridium difficile-associated disease in North America and Europe.
    Kuijper EJ; Coignard B; Tüll P; ; ;
    Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The simple predictors of pseudomembranous colitis in patients with hospital-acquired diarrhea: a prospective observational study.
    Yang BK; Do BJ; Kim EJ; Lee JU; Kim MH; Kang JG; Kim HS; Kim KH; Jang MK; Lee JH; Kim HY; Shin WG
    Gut Liver; 2014 Jan; 8(1):41-8. PubMed ID: 24516700
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Emergence and global spread of epidemic healthcare-associated Clostridium difficile.
    He M; Miyajima F; Roberts P; Ellison L; Pickard DJ; Martin MJ; Connor TR; Harris SR; Fairley D; Bamford KB; D'Arc S; Brazier J; Brown D; Coia JE; Douce G; Gerding D; Kim HJ; Koh TH; Kato H; Senoh M; Louie T; Michell S; Butt E; Peacock SJ; Brown NM; Riley T; Songer G; Wilcox M; Pirmohamed M; Kuijper E; Hawkey P; Wren BW; Dougan G; Parkhill J; Lawley TD
    Nat Genet; 2013 Jan; 45(1):109-13. PubMed ID: 23222960
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed.
    Villafuerte-Gálvez JA
    Clin Infect Dis; 2021 Jun; 72(12):e1090-e1092. PubMed ID: 33320187
    [No Abstract]   [Full Text] [Related]  

  • 90. Appendectomy and Clostridium difficile colitis: relationships revealed by clinical observations and immunology.
    Sanders NL; Bollinger RR; Lee R; Thomas S; Parker W
    World J Gastroenterol; 2013 Sep; 19(34):5607-14. PubMed ID: 24039352
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clostridium difficile infection: an undeniably common problem among hematopoietic transplant recipients.
    Zacharioudakis IM; Zervou FN; Ziakas PD; Mylonakis E
    Int J Hematol; 2014 Nov; 100(5):514-5. PubMed ID: 25139684
    [No Abstract]   [Full Text] [Related]  

  • 92. A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.
    Larocque M; Chénard T; Najmanovich R
    BMC Syst Biol; 2014 Oct; 8():117. PubMed ID: 25315994
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of fiber supplementation on the microbiota in critically ill patients.
    O'Keefe SJ; Ou J; Delany JP; Curry S; Zoetendal E; Gaskins HR; Gunn S
    World J Gastrointest Pathophysiol; 2011 Dec; 2(6):138-45. PubMed ID: 22180847
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Closing in on C. difficile infection.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2019 Oct; 16(10):581. PubMed ID: 31467436
    [No Abstract]   [Full Text] [Related]  

  • 95. [Diarrhea during enteral feeding].
    Schneider SM; Hébuterne X
    Presse Med; 2003 Jun; 32(20):935-41. PubMed ID: 12876540
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The seen and the unseen: clinical guidelines and cost-effective care.
    Chang-Panesso M; Humphreys BD
    J Am Soc Nephrol; 2014 Nov; 25(11):2390-2. PubMed ID: 24876118
    [No Abstract]   [Full Text] [Related]  

  • 97. A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model.
    Kondepudi KK; Ambalam P; Karagin PH; Nilsson I; Wadström T; Ljungh Å
    Microbiol Immunol; 2014 Oct; 58(10):552-8. PubMed ID: 25059277
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism.
    Pettit LJ; Browne HP; Yu L; Smits WK; Fagan RP; Barquist L; Martin MJ; Goulding D; Duncan SH; Flint HJ; Dougan G; Choudhary JS; Lawley TD
    BMC Genomics; 2014 Feb; 15():160. PubMed ID: 24568651
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile.
    Kondepudi KK; Ambalam P; Nilsson I; Wadström T; Ljungh A
    Anaerobe; 2012 Oct; 18(5):489-97. PubMed ID: 22940065
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.